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Abstract: 19 
 20 
Purpose: We investigated if oral ingestion of ibuprofen influenced leucocyte recruitment and 21 
infiltration following an acute bout of traditional resistance exercise. Methods: Sixteen male 22 
subjects were divided into two groups that received the maximum over-the-counter dose of 23 
ibuprofen (1200 mg d-1) or a similarly administered placebo following lower body resistance 24 
exercise. Muscle biopsies were taken from m.vastus lateralis and blood serum samples were 25 
obtained before and immediately after exercise, and at 3 h and 24 h after exercise. Muscle 26 
cross-sections were stained with antibodies against neutrophils (CD66b and MPO) and 27 
macrophages (CD68). Muscle damage was assessed via creatine kinase and myoglobin in 28 
blood serum samples, and muscle soreness was rated on a ten-point pain scale. Results: The 29 
resistance exercise protocol stimulated a significant increase in the number of CD66b+ and 30 
MPO+ cells when measured 3 h post exercise. Serum creatine kinase, myoglobin and 31 
subjective muscle soreness all increased post-exercise. Muscle leucocyte infiltration, creatine 32 
kinase, myoglobin and subjective muscle soreness were unaffected by ibuprofen treatment 33 
when compared to placebo. There was also no association between increases in inflammatory 34 
leucocytes and any other marker of cellular muscle damage. Conclusion: Ibuprofen 35 
administration had no effect on the accumulation of neutrophils, markers of muscle damage 36 
or muscle soreness during the first 24 h of post-exercise muscle recovery. 37 
Key Words: Exercise recovery, NSAID treatment, inflammation, resistance exercise, 38 
leucocyte. 39 
40 
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Introduction: 41 
Unaccustomed resistance exercise often results in tissue damage and inflammation, leading to 42 
delayed onset muscle soreness (DOMS) and a consequent reduction in force production 43 
(Faulkner et al., 1993;Tidball, 1995). Animal models and in vitro studies have identified that 44 
local and systemic inflammation exerts a regulatory influence during the different phases of 45 
muscle recovery, including myofibrillar disruption, cellular necrosis, satellite cell activation, 46 
maturation and subsequent regeneration and adaptation (Fridén et al., 1981;Armstrong et al., 47 
1991). Thus, post-exercise inflammation is intimately necessary and a key feature of the 48 
normal process of tissue regeneration and adaptation following acute muscle damage. 49 
However, excessive inflammation is considered a potential cause of prolonged post-exercise 50 
muscle soreness and may have a negative effect on muscle recovery (Armstrong et al., 51 
1991;Smith, 1991); consequently strategies to reduce or counteract inflammation are 52 
commonly implemented to aid in improving muscle recovery after exercise (Urso, 2013).  53 
 54 
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used as a treatment 55 
strategy in exercise and sports medicine to assist with recovery from exercise-induced 56 
inflammation, particularly following soft-tissue injury. NSAIDs inhibit the cyclooxygenase 57 
(COX-1 and 2) enzymes and consequently the formation of prostanoids (prostaglandins, 58 
prostacyclins and thromboxanes) that play a diverse roll in acute inflammation (Markworth et 59 
al., 2013). Prostanoids stimulate an acute inflammatory process by controlling local blood 60 
flow, vascular permeability, leucocyte infiltration, and triggering sensations of pain 61 
(Markworth et al., 2013;Urso, 2013). In animal models of acute muscle damage, treatment 62 
with NSAIDs blunts the infiltration of leucocytes into muscle tissue (Lapointe et al., 63 
2003;Bondesen et al., 2004) and causes a reduction in creatine kinase (CK) (Mishra et al., 64 
1995). Consequently, NSAIDs can also inhibit myofiber regeneration, satellite cell 65 
proliferation and differentiation, and overload-induced muscle hypertrophy (Mishra et al., 66 
1995;Bondesen et al., 2004;Bondesen et al., 2006). These findings provide preliminary 67 
evidence that NSAIDs compromise the physiological link between processes of acute muscle 68 
damage, inflammation and cellular regeneration.  69 
      70 
Research into the effects of NSAIDs on exercise-induced muscle damage and 71 
inflammation has produced equivocal findings. In exercise models, NSAID administration 72 
has been shown to attenuate post-exercise DOMS in some (Baldwin et al., 2001;Tokmakidis 73 
et al., 2003;Paulsen et al., 2010), but not all studies (Trappe et al., 2002;Krentz et al., 74 
2008;Mikkelsen et al., 2009;Hyldahl et al., 2010). While a precise cellular mechanism for an 75 
analgesic effect of NSAIDs remains unclear, it has been largely ascribed to their effect on 76 
prostaglandin synthesis and the capacity of NSAIDs to interfere with aspects of inflammatory 77 
cell function (Hersh et al., 2000;Peterson et al., 2003). Previous research has demonstrated 78 
that oral consumption of both ibuprofen, a non-selective NSAID and acetaminophen, an 79 
analgesic also known as paracetamol, had no effect on macrophage infiltration at 24 h 80 
following an eccentric exercise protocol (Peterson et al., 2003). Similarly treatment with 81 
naproxen, another non-selective NSAID, had no effect on the infiltration of leucocyte 82 
common antigen positive cells following a unilateral, isotonic resistance exercise protocol 83 
(Bourgeois et al., 1999). Interestingly, Paulsen et al., (2010) suggested a blunting effect of the 84 
COX-2 specific celecoxib following maximum eccentric muscle contractions (Paulsen et al., 85 
2010). This research identified a tendency for higher monocyte/macrophage numbers in 86 
subjects within the placebo group, and those subjects who were identified as ‘high-87 
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responders’ to the exercise protocol based on the number of inflammatory leucocytes 88 
(Paulsen et al., 2010). Although this is not a particularly robust finding, it has led to the 89 
hypothesis that NSAIDs may influence leucocyte infiltration in skeletal muscle when a 90 
sufficiently strong and early inflammatory reaction is present (Paulsen et al., 2010). This 91 
hypothesis would suggest that the intensity of the exercise stimulus and the consequent 92 
muscle-damage response will be largely influential in determining the effect of a 93 
pharmacologically based anti-inflammatory intervention.    94 
 95 
Conflicting findings also exist with regard to the effect of NSAIDs on the 96 
regenerative capacity of skeletal muscle following exercise-induced muscle damage. The 97 
non-selective COX inhibitor ibuprofen blunted skeletal muscle protein synthesis (Trappe et 98 
al., 2002) while local intramuscular infusion of indomethacin (Mikkelsen et al., 2011) and the 99 
oral administration of the COX-2 selective NSAID celecoxib (Burd et al., 2010;Paulsen et al., 100 
2010) had no such effect. Similarly, treatment with indomethacin inhibited post-exercise 101 
satellite cell proliferation (Mikkelsen et al., 2009). Recent work from our group demonstrated 102 
that treatment with ibuprofen inhibited early translational signalling responses involved in 103 
post-exercise muscle hypertrophy (Markworth et al., 2014). A clear mechanistic pathway for 104 
NSAIDs to influence the physiological link between post-exercise inflammation and skeletal 105 
muscle regeneration remains elusive. 106 
 107 
These discrepancies in the research to date are likely due to differences in the exercise 108 
protocol (concentric vs. eccentric muscle contractions), the training status of subjects, the 109 
timing of muscle biopsies, and the type of NSAID, the dosage administered, and method of 110 
administration .  Further research is required to determine whether NSAID administration 111 
affects the infiltration of leucocyte populations following exercise-induced muscle damage 112 
and how this influences post-exercise adaptive pathways. The aim of the present study was to 113 
investigate if oral administration of the NSAID ibuprofen influenced skeletal muscle 114 
leucocyte infiltration during the first 24 h after muscle-damaging resistance exercise. We also 115 
aimed to explore how any changes in leucocyte infiltration were related to markers of muscle 116 
damage, including circulating muscle proteins CK and myoglobin, and subjective markers of 117 
muscle soreness. We hypothesized that the ingestion of ibuprofen following acute resistance 118 
exercise would not influence the infiltration of leucocytes, however it would attenuate 119 
sensations of DOMS.  120 
121 
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Materials and Methods: 122 
Participants: 123 
As described previously, sixteen healthy male subjects were recruited to participate in the 124 
study (Table 1) (Markworth et al., 2013). It is important to note that the purpose of the 125 
original study by Markworth et al 2013 was to………. . as opposed to the aim of the present 126 
study which was to determine the effect of oral ingestion of ibuprofen on leucocyte 127 
recruitment and infiltration following an acute bout of traditional resistance exercise.  While 128 
the subjects and experimental design are the same in both studies the aims and dependent 129 
variables reported are different. Exclusion criteria included participation in a lower body 130 
resistance exercise program within the last 6 months to ensure a muscle damage response 131 
from the exercise stimulus, and/or previous chronic treatments with anti-inflammatory 132 
medication. Participants also completed a medical screening to identify any potential risk 133 
factors for them to perform strenuous physical activity. 134 
 135 
Ethics approval: 136 
All procedures involved in this study were approved by the Deakin University Human 137 
Research Ethics Committee (DUHREC 2010-019) and muscle sampling procedures were 138 
performed in accordance with the Helsinki declaration. Each participant was provided with 139 
written and oral details of the nature and requirements of the study and provided written 140 
consent to participate.  141 
 142 
Familiarization: 143 
Each participant completed a familiarization and strength testing session at least 7 days prior 144 
to completing the exercise protocol. Details of the familiarization session have been 145 
described previously (Markworth et al., 2013). Briefly, subjects performed repetition 146 
maximum testing for the Smith machine-assisted squat, the leg press and the leg extension to 147 
determine their experimental exercise load (80% of a 1 repetition maximum (1RM)). The 148 
maximum weight the subject could lift for 5-8 reps was determined, and these data were 149 
entered into the Brzycki equation to predict 1RM (Whisenant et al., 2003). Subjects were 150 
asked to abstain from any further activity until the completion of the trial. 151 
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 152 
Experimental Procedures: 153 
The participants reported to the laboratory on the morning of the trial in an overnight fasted 154 
state. They were asked to abstain from caffeine, tobacco and alcohol for the 24 h preceding 155 
the trial.  Participants rested in a supine position for 30 min, following which the first muscle 156 
biopsy sample was taken. Each participant then completed a 10 min warm-up protocol 157 
comprised of 5 min of low intensity cycling on a stationary bike, and one low-intensity set of 158 
each exercise at a weight of each subject’s own choice within the range of 30-50% 1RM. The 159 
resistance exercise session consisted of 3 sets of 8-10 repetitions performed on a Smith 160 
machine assisted squat, a 45-degree leg press and a leg extension at 80% of a predicted 1RM. 161 
The exercises were performed as a circuit with 1 min rest permitted between exercises and 3 162 
min rest between sets. This protocol has been used previously and has been a sufficient 163 
stimulus to activate inflammatory signalling pathways (Vella et al., 2012) and was 164 
implemented to replicate a commonly used exercise routine. After exercise, the subjects 165 
rested while subsequent muscle biopsy samples were collected. After the 3 h biopsy, 166 
participants were provided a standardized meal and were allowed to go home. The following 167 
morning, participants reported to the laboratory in an over-night fasted state for a 24 h muscle 168 
biopsy and blood sample. 169 
 170 
Standardized meals  171 
Standardized meals were provided to participants on the night before the trial, (carbohydrate 172 
57%, fat 22%, protein 21%), immediately following the 3 h muscle biopsy (carbohydrate 173 
71%, fat 13%, protein 18%), and in the evening (carbohydrate 64%, fat 27%, protein 18%) on 174 
the day of the exercise trial. Participants were permitted to drink water ad libitum and were 175 
asked to report if they could not finish their allocated meals. This nutrition plan was included 176 
to ensure that each participant received the same relative percentage of macro- and micro-177 
nutrients.  178 
 179 
NSAID Administration: 180 
Prior to exercise, participants were randomly assigned in a double-blind method, to consume 181 
either the maximum recommended dose of ibuprofen (IBU, n = 8) or a placebo control 182 
(gelatin capsules identical in appearance containing powdered sugar in place of ibuprofen) 183 
(PLA, n = 8). The IBU group consumed three doses of 400 mg of ibuprofen throughout the 184 
trial day. The first dose was administered immediately prior to the first muscle biopsy 185 
sample. Participants were instructed to consume the following two doses at 6 h and 12 h 186 
following the exercise protocol. Follow-up phone calls from the research team ensured 187 
compliance. To ensure this dosing structure was appropriate to maintain biologically active 188 
levels of ibuprofen, ibuprofen concentration was measured in blood serum samples and these 189 
data are reported elsewhere (Markworth et al., 2013). 190 
 191 
Sample collection: 192 
Venous blood samples were drawn prior to exercise, within 5 min post exercise (here-after 193 
referred to as 0 h post-exercise), and at 1, 2, 3 and 24 h post-exercise. Blood samples were 194 
drawn through an indwelling catheter into VACUETTE serum tubes (Greiner,Bio-One, 195 
Stonehouse UK). Whole blood was allowed to clot at room temperature. Samples were then 196 
centrifuged at 1,000  g for 10 min. The serum layer was collected and stored at -80°C for 197 
subsequent analysis.  198 
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 Muscle biopsy samples were obtained from the vastus lateralis muscle under local 199 
anaesthesia (Xylocaine 1%) using a percutaneous needle biopsy technique modified to 200 
include suction (Buford et al., 2009). To minimize interference from the biopsy procedure, 201 
samples prior to exercise and at 24 h post exercise were taken from the same leg, while 202 
samples taken at 0 and 3 h post-exercise were taken from the contralateral leg. Samples 203 
obtained within the same leg were taken at least 5cm from the previous incision site. We have 204 
previously reported that this technique is effective for minimizing the risk of any 205 
inflammation arising from the biopsy procedure confounding exercise-induced inflammation 206 
(Vella et al., 2012). A section of excised tissue was immersed in Tissue-Tek and stored at -207 
80°C until further analysis.   208 
 209 
Immunohistochemistry: 210 
Cross sections (8 μm) of muscle tissue were cut using a microtome at -20 ⁰C (CM3050, 211 
Leica, Germany) and mounted on microscope slides (Superfrost Plus, Thermo Scientific, 212 
MA, USA), air-dried and stored at -80 °C. Each subject’s muscle sections from all time 213 
points were mounted on the same microscope slide. Serial muscle cross-sections were stained 214 
with three different leucocyte antibodies, MPO (#EBM-11, DakoCytomation, Glostrup, 215 
Denmark; dilution 1:2000), CD66b (#CLB-B13.9, Sanquin Reagents, Amsterdam, The 216 
Netherlands; dilution 1:500) and CD68 (#EBM-11, DakoCytomation, Glostrup, Denmark; 217 
dilution 1:300). Furthermore, the sections were also stained with dystrophin antibody for 218 
visualizing borders of muscle fibers. Detailed information about the primary antibodies is 219 
listed in Table 2. 220 
Sections were fixed in 4 % paraformaldehyde solution in a staining jar for 5 min at 221 
room temperature and rinsed twice for 10 min in phosphate buffered saline (PBS) containing 222 
0.5 % Tween 20 (Sigma-Aldrich). The microscope slides were moved into a humidified 223 
chamber and non-specific binding sites were blocked with 1% bovine serum albumin (BSA) 224 
on the section for 45 min at room temperature. Sections were incubated overnight with 225 
leucocyte and dystrophin antibodies diluted (dilutions are listed in Table 2) in 1% BSA at 226 
4°C. After overnight incubation, the slides were washed three times for 10 min in PBS-227 
Tween in a staining jar. Slides were moved back to the humidified chamber and sections were 228 
incubated for 45 min with secondary antibodies diluted 1:200 in 1% BSA at room 229 
temperature. Alexa Fluor® 594 F(ab’)2 fragment of goat anti-rabbit and  Alexa Fluor®488 230 
anti-mouse IgG  (Invitrogen, Eugene, Oregon, USA) were used as a secondary antibodies. 231 
The fluorochrome-stained sections were washed three times for 10 min in PBS-Tween. After 232 
the last washing in PBS-Tween, the sections were mounted on ProLong® Gold Antifade 233 
reagent with DAPI (Invitrogen, Eugene, Orgeon, USA).  234 
Muscle sections were visualized using a high-resolution camera (DP72, Olympus, 235 
Japan) mounted on a microscope (BX61, Olympus, Japan) with a fluorescence light source 236 
(X-Cite 120PCQ, EXFO, Canada). The number of MPO, CD66b and CD68 positive cells (as 237 
well as the total number of muscle fibres from the area included) was counted. Data was 238 
calculated as percentage of MPO, CD66b or CD68 positively stained cells per 100 skeletal 239 
muscle fibres. Areas of sections that contained freeze damage or were folded due to the 240 
cutting procedure were not included in the analysis. 241 
 242 
Biochemical assays:  243 
Serum creatine kinase activity in pre- and post-exercise blood samples was analyzed using an 
244 
enzymatic assay (CK-NAC kit, CDT14010, Thermo-Fisher Scientific Clinical Diagnostics, 
245 
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Sydney, Australia) and an automated clinical analyser (Cobas Mira, Roche Diagnostics, 
246 
Germany). Serum myoglobin concentration was also measured in these samples using an 
247 
immunoassay (Roche Diagnostics, Germany) and an automated clinical analyzer (Cobas 
248 
E411, Roche Diagnostics, Germany). The intra-assay coefficient of variation was 10.4% for 
249 
creatine kinase and 1.7% for myoglobin.  
250 
 
251 
 
252 
Muscle soreness assessment: 253 
Upon arrival at the laboratory and prior to the first muscle biopsy procedure subjects were 254 
asked to rate their subjective muscle soreness on a 0-10 visual analogue scale. The subjects 255 
were instructed to contract, stretch and palpate the quadriceps muscle to assess general 256 
muscle soreness. In both instances 0 was considered to represent no pain and correspondingly 257 
a rating of 10 was considered to represent intense pain. 258 
 259 
Statistics: 260 
Data are expressed as means ± SEM. Prior to analysis the data displaying a lack of normality 261 
were log transformed to stabilise variance. Data were analysed using a two-way ANOVA 262 
with repeated measures for time. The sphericity adjustment was checked, and if required, a 263 
Greenhouse-Geisser epsilon correction was applied. Where no significant effect for treatment 264 
was observed, we explored pair-wise comparisons between individual time-points using the 265 
Least Significant Difference (LSD) of means. Bivariate relationships were examined with a 266 
Spearman rank correlation test. Statistical analyses were performed using GenStat for 267 
Windows 16th Edition (VSN International, Hemel Hempstead, UK). Statistical significance 268 
was set at P < 0.05.269 
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Results: 270 
Muscle soreness: 271 
Muscle soreness showed a main effect for time (p<0.01), suggesting that the exercise 272 
protocol was sufficient to induce a muscle stress response. No effect of ibuprofen treatment 273 
was observed (Figure 1).   274 
 275 
Immunohistochemistry: 276 
The number of MPO+ cells per 100 myofibres analysed showed a main effect for time (P < 277 
0.01). No main effect for treatment (P = 0.250) or time x treatment (P = 0.709) was observed 278 
(Figure 2A). LSD pairwise comparisons indicated a significant increase in MPO+ cells at all 279 
sampling time points post-exercise. The greatest increase in MPO+ cells was observed at 3 h 280 
post-exercise (Figure 2B). Similarly, the number of CD66b+ cells per 100 myofibres showed 281 
a main effect for time (P < 0.05), with no main effect for treatment (P = 0.149) or time x 282 
treatment interaction (P = 0.907) (Figure 2C). LSD pairwise comparisons indicated a 283 
significant increase in the number of CD66b+ cells at 3 h post exercise (Figure 2D). The 284 
number of CD68+ cells per 100 myofibres analysed showed no effect for time (P = 0.061), 285 
treatment (P = 0.530) or time x treatment interaction (P = 0.688) (Figure 2D). MPO+, 286 
CD66b+, and CD68+ cells were observed within the endomysium and the perimysium, with 287 
no cellular infiltration occurring at any time point (Figure 2E). Representative images for 288 
each cell surface marker are presented in Figure 3.    289 
 290 
Serum proteins: 291 
Serum CK activity demonstrated a main effect for time (P < 0.01) with no effect for 292 
treatment (P = 0.843) or time x treatment interaction (P = 0.494) (Figure 4A). LSD 293 
comparisons revealed that serum CK increased from pre-exercise values at 2 h post-exercise 294 
and peaked at 24 h post-exercise (Figure 4B). Similarly, serum myoglobin concentration 295 
showed a main effect for time (P < 0.01) with no effect for treatment (P = 0.710) or time x 296 
treatment interaction (P = 0.666) (Figure 4C). LSD comparisons demonstrated that the 297 
biggest increase in serum myoglobin concentrations occurred at 1 h post-exercise and 298 
remained significantly elevated up to 3 h post exercise (Figure 4D). 299 
 300 
Correlation analysis: 301 
In general, large inter-individual differences were seen in the appearance of all of the 302 
leucocyte cell types. Results from the Spearman rank correlation test showed no correlation 303 
between the histochemical appearance of inflammatory leucocytes, biological markers of 304 
muscle damage and subjective markers of muscle soreness (Table 2). Anecdotally, three 305 
subjects were identified as the highest responders in the appearance of cell surface markers 306 
applicable for localization of neutrophils (one subject within the placebo group, and two 307 
subjects within the ibuprofen group).  However, these subjects showed no significant increase 308 
in CK, myoglobin or subjective markers of muscle damage when compared with the other 309 
subjects. Interestingly, subject 5 recorded the highest number of CD66b+ cells and MPO+ 310 
cells, whereas he presented with the lowest subjective rating for DOMS.  311 
312 
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Discussion: 313 
The main finding of this study was that ibuprofen, a non-selective COX inhibitor, had no 314 
effect on the histological detection of leukocytes following an acute bout of traditional 315 
resistance exercise. Serum CK and myoglobin, and muscle soreness also did not change in 316 
response to ibuprofen. Furthermore, no correlation was observed between the accumulation 317 
of inflammatory leucocytes, increases in CK or myoglobin, and sensations of DOMS. These 318 
observations suggest that the intramuscular infiltration of inflammatory white blood cells, nor 319 
an increase in serum level of intramuscular proteins, is not predictive of post-exercise muscle 320 
soreness. 321 
The current study focused on the acute local inflammatory response to exercise-induced 322 
muscle damage. Our protocol was effective in inducing muscle soreness as shown in Figure 323 
1.  It is important to note that was have previously reported this exercise-induced stress 324 
response (Vella et al., 2014). However, we felt it was necessary to re-emphasise this response 325 
here. In the present study we identified an increase in the histological appearance of CD66b+ 326 
and MPO+ cells that peaked at 3 h post exercise and found no effect of NSAID treatment. 327 
CD66b is a highly specific cell surface marker for detecting human neutrophils, and this is 328 
the first paper to show a small but significant increase in the intramuscular number of 329 
CD66b+ cells following acute resistance exercise. Paulsen et al. (2012) were unable to 330 
identify any change in the number of CD66b+ cells in the elbow flexors at 1 h, 2, 4 or 7 days 331 
following 70 maximal eccentric contractions (Paulsen et al., 2013). Differences in the timing 332 
of muscle biopsy samples may explain the discrepancy between the two trials, and suggest 333 
that neutrophils may be involved in the acute phase inflammatory response to resistance 334 
exercise. We also identified a small but significant increase in the number of MPO+ cells at 335 
all sampled time points, with a peak in expression at 3 h post exercise. MPO has typically 336 
been used to detect changes in neutrophils, and an increased number of MPO+ cells have been 337 
reported following high-force eccentric muscle contractions (Mahoney et al., 2008;MacNeil 338 
et al., 2011). However, MPO is also expressed on the lysosomes of monocytes and has been 339 
detected on basophils and eosinophils, perhaps providing a reason why there were a higher 340 
number of MPO+ cells when compared to CD66b+ cells detected in the present study (Paulsen 341 
et al., 2013). 342 
No change was identified in the number of CD68+ cells. CD68 cell counts are widely 343 
used as a marker of monocyte/macrophage infiltration. However, CD68 may also be 344 
expressed on other cell types including satellite cells and fibroblasts (Paulsen et al., 2013). 345 
Other researchers have been able to identify a change in CD68+ cells following exercise-346 
induced muscle damage (Peterson et al., 2003;Mahoney et al., 2008;MacNeil et al., 2011). 347 
Each of these studies have used a high-force maximal eccentric muscle contraction protocol, 348 
which may suggest that the detection of CD68+ cells is dependent on the extent of skeletal 349 
muscle damage.   350 
Previous research exploring the effect on NSAIDs on post-exercise inflammation has 351 
produced equivocal findings. Earlier research from in-vivo rodent trials demonstrated a 352 
blunted inflammatory response to eccentric muscle contractions following the administration 353 
of both selective and non-selective NSAIDs (Lapointe et al., 2002a;Lapointe et al., 354 
2002b;Bondesen et al., 2004;Bondesen et al., 2006). However, these findings are yet to be 355 
supported in human trials (Bourgeois et al., 1999;Peterson et al., 2003;Tokmakidis et al., 356 
2003). Petersen et al. (2003) found no effect of oral ibuprofen administration on the 357 
appearance of CD68+ cells 24 h following 100 eccentric muscle contractions (Peterson et al., 358 
2003). Similarly, Tokmakidis showed no effect of ibuprofen on circulating white blood cells 359 
24 h following an eccentric exercise protocol (Tokmakidis et al., 2003). Paulsen et al. (2010) 360 
 11 
proposed the concept of an inflammatory threshold, suggesting that NSAIDs may only 361 
influence post-exercise inflammation in response to a sufficiently strong inflammatory 362 
stimulus (Paulsen et al., 2010). It was suggested that the absence of an intramuscular 363 
prostaglandin response to exercise, specifically PGE2, could explain the lack of an NSAID 364 
effect on leucocyte recruitment (Trappe et al., 2001;Paulsen et al., 2010). Interestingly, our 365 
group recently reported an increase in serum PGE2 in samples that were obtained during the 366 
same exercise trials as those currently reported (Markworth et al., 2013). This change in 367 
serum PGE2 was blunted by the administration of ibuprofen and suggests that in the presence 368 
of a blunted prostaglandin response to exercise, NSAID treatment had no effect on leucocyte 369 
recruitment within skeletal muscle. Although this finding does not refute the possibility of an 370 
inflammatory threshold, based on our previous findings (Markworth et al., 2013), it is 371 
reasonable to suggest that the presence of an exercise-induced serum prostaglandin response 372 
is not the required underlying mechanism for neutrophil infiltration of muscle during the 373 
early hours of post-exercise recovery. 374 
In accordance with previous studies, resistance exercise resulted in an increase in 375 
serum CK and myoglobin, and subjective muscle soreness (Nosaka et al., 2006). Although 376 
large inter-individual variations in the human response to exercise can make it difficult to 377 
establish causal relationships, there was no relationship between the appearance of leucocytes 378 
and blood-derived markers of muscle damage or sensations of muscle soreness. Interestingly, 379 
the subject with the highest number of CD66b+ and MPO+ cells presented with the lowest 380 
subjective rating of DOMS. These findings provide support for the assumption that leucocyte 381 
recruitment and inflammation do not consistently cause DOMS.  382 
From animal studies it appears that cellular events in post-exercise inflammation, 383 
occur concomitantly with the onset of DOMS (Armstrong et al., 1991;Faulkner et al., 1993). 384 
The mechanistic link has been proposed to be a leucocyte-mediated release of cytotoxic 385 
substances and reactive oxygen species as a bi-product of phagocytosis (Connolly et al., 386 
2003). Furthermore, the prostaglandin response to exercise has been shown to occur 387 
concurrently to the onset of DOMS, and is known to influence both the recruitment of 388 
inflammatory leucocytes and neural afferents to pain (Markworth et al., 2013). However, in 389 
line with the current findings, the accumulation of inflammatory leucocytes in human skeletal 390 
muscle tissue during exercise recovery appears to be both spatially and temporally out of 391 
phase with the development of DOMS (Paulsen et al., 2010). Malm et al. (Malm et al., 2004) 392 
explored the concept that the activation of local leucocytes present in the epimysium may be 393 
involved in the regulation of DOMS. This hypothesis has since received support from both 394 
rodent (Gibson et al., 2009) and human trials (Crameri et al., 2007;Raastad et al., 2010) and 395 
presents a promising area for future research. 396 
 397 
Conclusion: 398 
This is the first study to demonstrate that ibuprofen administration has no effect on the 399 
histological appearance of inflammatory white blood cells following an acute bout of 400 
traditional resistance exercise. We also found no effect of ibuprofen administration on blood 401 
markers of muscle damage or subjective muscle soreness, and no significant correlations 402 
between leucocyte numbers and post-exercise muscle damage or soreness. Future research 403 
needs to explore the possibility of an inflammatory threshold above which NSAID 404 
administration influences post-exercise inflammation. The underlying cause of post-exercise 405 
muscle soreness also remains largely unknown. Future investigations are needed to determine 406 
the role that inflammation plays in exercise-induced DOMS. 407 
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Figure Legends: 420 
 421 
Figure 1: Subjective rating for delayed onset muscle soreness (DOMS) (B). Values depicted 422 
are mean values ± SEM. * denotes statistical significance from pre-exercise values (p<0.05). 423 
White bars = PLA group; black bars = IBU group. This figure has been adapted from Vella et 424 
al. (2014). 425 
 426 
Figure 2: Immunohistochemistry data for muscle cells staining positive for myeloperoxidase 427 
(MPO), showing group specific data (A) and collapsed data (B), CD66b showing group 428 
specific data (C) and collapsed data (D), and CD68 showing group data only (E). Data 429 
represent the mean number of positively stained cells per 100 fibres analysed ± SEM. ** 430 
denotes statistical significance from pre-exercise values (p<0.01). * denotes statistical 431 
significance from pre-exercise values (p<0.05). ^ denotes statistical significance from 0 h 432 
post-exercise (p<0.05). White bars =PLA group; black bars = IBU group.  433 
 434 
Figure 3: Immunohistochemical analysis of skeletal muscle samples following a bout of 435 
resistance exercise. Sections were probed with antibodies raised against leucocyte cell surface 436 
markers (green; Figure 3A– MPO, Figure 3B – CD66b, Figure 3C – CD68) and dystrophin 437 
(red), while DAPI was used to stain nuclei (blue). Scale bars = 50µm. 438 
 439 
Figure 4: Blood derived proteins creatine kinase (A and B) and myoglobin (C and D). Values 440 
depicted are mean values ± SEM. Figures A and C represent data divided into two treatment 441 
groups; figures B and D represent collapsed data. *denotes statistical significance from pre-442 
exercise values (p<0.05). ** denotes statistical significance from pre-exercise values 443 
(p<0.01). ^ denotes statistical significance from 1, 2 and 3 h post exercise (p<0.05). White 444 
bars = PLA; black bars = IBU. 445 
446 
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Tables: 447 
Table 1: Subject characteristics and strength testing data. Values are mean values ± SEM. No 448 
significant differences were observed between the two groups. 449 
 450 
  Characteristics Strength (1RM) 
  Age (y) Height (m) Body mass 
(kg) 
BMI Squat (kg) Leg Press 
(kg) 
Leg 
Extension 
(kg) 
PLA 23.9                              
± 1.3 
1.89                           
± 0.1 
86.9                                      
± 4.5 
24.5                 
± 1.2 
94.9                          
± 5.4 
237                               
± 17 
236                          
± 18 
IBU 23                 
± 0.5 
1.89                                    
± 0.1 
89.1                                      
± 4.4 
24.8              
± 0.8 
91.9                                
± 6.0 
240                              
± 15 
196                               
± 22 
PLA, placebo; IBU, Ibuprofen; BMI, body mass index 451 
 452 
Table 2: Spearman rank correlation analysis. Values depicted are the correlation coefficient. 453 
Statistical significance was set at p < 0.05. No statistically significant correlations were 454 
observed.  455 
 456 
  CK MYO CD68 CD66b MPO ROM DOMS 
CK - 0.74 -0.27 0.11 0.16 0.13 0.05 
MYO - - 0.45 0.12 -0.13 0.25 0.25 
CD68 - - - -0.14 -0.19 -0.01 0.07 
CD66b - - - - 0.40 0.67 0.38 
MPO - - - - - 0.02 -0.19 
ROM - - - - - - 0.65 
DOMS - - - - - - - 
CK, creatine kinase; MYO, myoglobin; MPO, Myeloperoxidase; ROM, range of movement; 457 
DOMS, delayed-onset muscle soreness. 458 
 459 
 460 
461 
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